Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.
The major factors fuelling the global renal biomarkers market are increased incidence of kidney diseases, large geriatric population and increasing prevalence of multiple co-morbidities.
Market Analysis and Insights: Global Renal Biomarkers Market
The global Renal Biomarkers market size is projected to reach US$ 1005.8 million by 2026, from US$ 964.4 million in 2020, at a CAGR of 4.0%% during 2021-2026.
Global Renal Biomarkers Scope and Market Size
Renal Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Renal Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Abbott Diagnostics
F.Hoffmann
Beckman Coulter
Siemens Healthcare Diagnostics
Thermo Fisher Scientific
Astute Medical
Abbott
BioMerieux SA
Randox Laboratories
Enzyme Linked Immunosorbent Assay (ELISA)
Enzymatic Assay
Turbidimetric Immunoassay
Others
Diagnosis and Disease Progression Monitoring
Research
Others
North America
Europe
China
Japan
Southeast Asia
India
The major factors fuelling the global renal biomarkers market are increased incidence of kidney diseases, large geriatric population and increasing prevalence of multiple co-morbidities.
Market Analysis and Insights: Global Renal Biomarkers Market
The global Renal Biomarkers market size is projected to reach US$ 1005.8 million by 2026, from US$ 964.4 million in 2020, at a CAGR of 4.0%% during 2021-2026.
Global Renal Biomarkers Scope and Market Size
Renal Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Renal Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Diagnostics
F.Hoffmann
Beckman Coulter
Siemens Healthcare Diagnostics
Thermo Fisher Scientific
Astute Medical
Abbott
BioMerieux SA
Randox Laboratories
Market segment by Type, the product can be split into
Enzyme Linked Immunosorbent Assay (ELISA)
Enzymatic Assay
Turbidimetric Immunoassay
Others
Market segment by Application, split into
Diagnosis and Disease Progression Monitoring
Research
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
